Cited by 67Cutaneous Melanoma Detection and ManagementTelemedicine and Telehealth ImplementationTechnology Adoption and User Behaviour

Consumer acceptance of patient-performed mobile teledermoscopy for the early detection of melanoma

Open access
Horsham, C., Loescher, L.J., Whiteman, D.C., Soyer, H.P., Janda, M.·2016·British Journal of Dermatology

Abstract

BACKGROUND: Mobile teledermoscopy allows consumers to send images of skin lesions to a teledermatologist for remote diagnosis. Currently, technology acceptance of mobile teledermoscopy by people at high risk of melanoma is unknown. OBJECTIVES: We aimed to determine the acceptance of mobile teledermoscopy by consumers based on perceived usefulness, ease of use, compatibility, attitude/intention, subjective norms, facilitators and trust before use. Consumer satisfaction was explored after use. METHODS: Consumers aged 50-64 years at high risk of melanoma (fair skin or previous skin cancer) were recruited from a population-based cohort study and via media announcements in Brisbane, Australia in 2013. The participants completed a 27-item questionnaire preteledermoscopy modified from a technology acceptance model. The first 49 participants with a suitable smartphone then conducted mobile teledermoscopy in their homes for early detection of melanoma and were asked to rate their satisfaction. RESULTS: The preteledermoscopy questionnaire was completed by 228 participants. Most participants (87%) agreed that mobile teledermoscopy would improve their skin self-examination performance and 91% agreed that it would be in their best interest to use mobile teledermoscopy. However, nearly half of participants (45%) were unsure about whether they had complete trust in the telediagnosis. The participants who conducted mobile teledermoscopy (n = 49) reported that the dermatoscope was easy to use (94%) and motivated them to examine their skin more often (86%). However, 18% could not take photographs in hard-to-see areas and 35% required help to submit the photograph to the teledermatologist. CONCLUSIONS: Mobile teledermoscopy consumer acceptance appears to be favourable. This new technology warrants further assessment for its utility in the early detection of melanoma or follow-up.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bjd.14630

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Teledermatology decreases the delays in the management of melanoma lesions.

    “This literature review suggests that teledermatology decreases the delays in the management of melanoma lesions [34-36,40,59], reduces the referrals to a dermatologist by avoiding unnecessary consultations [35,36,40] and limits the number of patients lost from follow-up [36,60].”

    From Use of Smartphones for Early Detection of Melanoma: Systematic Review (2018) · cites this paper as [59]

    The introductory passage (labelled Abstract in our copy; page unavailable) lists reduced waiting time as a general benefit of telemedicine and identifies mobile teledermoscopy as an application for melanoma diagnosis. It does not establish that teledermatology decreases delays in managing melanoma lesions specifically. The Discussion also reports a longer delay in receiving results in this study. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • Store-and-forward teledermatology is well-accepted by patients and caregivers.

    “Store-and-forward teledermatology is well-accepted by patients and caregivers [59,69,70].”

    From Use of Smartphones for Early Detection of Melanoma: Systematic Review (2018) · cites this paper as [59]

    The Abstract (page unavailable) reports patient satisfaction with store-and-forward teledermatology, but says it varied widely (42–93%). The Discussion (page unavailable) likewise describes mixed preferences for it. The paper does not report caregiver acceptance, so it supports the patient portion only, with a qualification. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Romero G, Cortina P, Vera E. [Telemedicine and teledermatology (II): current state of research on dermatology teleconsultations]. Actas Dermosifiliogr 2008; 99:586-97 (in Spanish).

Cited by

Sorted by citations

Authors
Horsham, C., Loescher, L. J., Whiteman, D. C., Soyer, H. P., & Janda, M.
Affiliations
  • Queensland University of Technology (AU)
  • University of Arizona (US)
  • QIMR Berghofer Medical Research Institute (AU)
  • Translational Research Institute (AU)
Corresponding author
Janda, M.
Venue
British Journal of Dermatology
Published
2016-09-02
Volume
175
Issue
6
Pages
1301-1310
ISSN
0007-0963 (ISSN-L)
OpenAlex
W2313926788
Cited by
67
References
32
Citations by year
2025: 2 · 2024: 3 · 2023: 13 · 2022: 8 · 2021: 4 · 2020: 9 · 2019: 6 · 2018: 15 · 2017: 5 · 2016: 2
FWCI
5.03
Type
journal article
Language
en
Open access
Locations
  • British Journal of Dermatology (publishedVersion)
  • PubMed (publishedVersion)
  • QUT ePrints (Queensland University of Technology) (submittedVersion)
Funders
  • PanPacific Skin Cancer Consortium
  • Institute of Health and Biomedical Innovation collaborative
  • National Health and Medical Research Council (1063061, 1073898)
Topics
  • Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Telemedicine and Telehealth Implementation
  • Social Sciences › Decision Sciences › Information Systems and Management › Technology Adoption and User Behaviour
Keywords
early melanoma detection, consumer acceptance, technology acceptance model, skin self-examination, dermatoscope, perceived usefulness, perceived ease of use, user satisfaction
MeSH terms
Ambulatory Care, Female, Humans, Male, Melanoma, Middle Aged, Skin Neoplasms, Patient Satisfaction, Telemedicine, Dermoscopy, Early Detection of Cancer

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review